Physician profile
Jason W Schultz
NPI 1952664039
$14,325.24
in general payments reported to CMS, 2019-2025
12 companies · $1,905 in 2025
The $1,905 reported for 2025 was more than what 89% of Oral & Maxillofacial Surgery providers received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,979 · 2020: $507 · 2021: $5,266 · 2022: $919 · 2023: $2,866 · 2024: $884 · 2025: $1,905.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,433 · Travel and Lodging: $2,222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,432.52 |
| Travel and Lodging | $2,221.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,733.62 | 2019-2025 | Na, Smartlock, Patient-Fitted Tmj Reconstructive Prosthesis System |
| Medical Device Business Services, INC. | $3,630.00 | 2021 | |
| Depuy Synthes Sales INC. | $2,924.25 | 2019-2023 | Trumatch, Vivigen Mis Delivery System, Matrixorthognathic |
| Zimmer Biomet Holdings, INC. | $793.02 | 2021 | |
| Straumann USA LLC | $410.36 | 2023-2024 | |
| Smith+Nephew, INC. | $263.18 | 2022-2024 | Stravix Pl, Stravix |
| Kls-Martin L.P. | $255.98 | 2020 | |
| Globus Medical, INC. | $153.85 | 2025 | Excelsius Gps |
| Nobel Biocare USA | $73.94 | 2022 | |
| Envista Holdings Corporation | $50.90 | 2025 | I-Cat Flxflx Mv |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.19 | 2019 | |
| Merck Sharp & Dohme LLC | $14.95 | 2025 | Bridion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Schultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.